For mild cases or other GI conditions, starting at even lower doses (0.125 mg weekly via precise syringe measurement from a 2.5mg/mL vial) and titrating over eight to twelve weeks per level can improve tolerability
Intramuscular injections bypass this, delivering B12 directly into the bloodstream for rapid use, benefiting those with malabsorption issues
Celiac disease-related conditions: Who to test
Helpful details to share include: Exactly how the sensation feels (tightness, choking, lump, fullness) When it occurs (always, after eating, at night, during stress) Any associated symptoms (heartburn, cough, voice change, weight loss, fever) Recent infections, new medications, and smoking or alcohol habits These details let clinicians prioritize tests and avoid unnecessary procedures
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
